Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00933556 · ClinicalTrials.gov registry record · Phase 2
A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT00933556 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 90 participants.
The verdict
NCT00933556, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the feasibility, safety and efficacy of oral probiotic, VSL#3 versus oral placebo for reducing colonization by VRE.
Interventions
- DIETARY_SUPPLEMENT VSL#3
- DIETARY_SUPPLEMENT sugar pill (placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00933556
The ClinicalTrials.gov registry entry for NCT00933556 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VSL#3 is the first listed.
NCT00933556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00933556 about?
NCT00933556 is a clinical study titled "A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE". The purpose of this study is to investigate the feasibility, safety and efficacy of oral probiotic, VSL#3 versus oral placebo for reducing colonization by VRE.
What is the current status of trial NCT00933556?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2008-10. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00933556?
The interventions under investigation include: VSL#3 (DIETARY_SUPPLEMENT), sugar pill (placebo) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00933556?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.